BEIJING, July 21, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it showcased the current line of sleep respiratory solution at the 5th Chinese Sleep Medicine Congress ("CSMC") in Nanchang, Jiangxi Province, from July 11-13, 2014.
The company presented the sleep respiratory solutions to the congress and reached out to clients and national sleep respiratory experts. The company also identified several well-known first-class hospitals in different regions as the model hospitals for the sleep respiratory solution.
Ms. Reyna Dong, Marketing Director of Dehaier's Sleep Respiratory Products Division stated, "The CSMC conference exposed us to key decision makers and experts and gave us the opportunity to showcase how the products integrate diagnosis, treatment and treatment evaluation. We will build on the attention from our presentation at the congress to market the solution to our first wave of model hospitals to be equipped with our solution."
About the Chinese Sleep Medicine Congress
Chinese Sleep Medicine Congress is one of the largest, most widely attended professional and comprehensive academic congress of sleep respiratory disease, aimed at promoting development and exchange of information between different regions. It strives to be the premier China-based sleep respiratory congress with world vision to exhibit state-of-the-art technology and encourage international and regional collaboration. The 5th CSMC brought together more than 1,000 nationally and internationally renowned experts, participants from China, the United States, Korea and Hong Kong in the sleep industry, as well as well-known medical equipment companies including Philips Respironics, ResMed and BMC Medical etc.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and ten software copyrights. More information may be found at http://www.dehaier.com.cn
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Dehaier Medical Systems Limited +86 10-5166-0080 Janice Wang Investors@dehaier.com.cn